- Top reward
- Not published
- Top severity paid
- Not published
- Assets in scope
- 3
- Public CVEs
- 0
- Last change
- No changes yet
At a glance
What to know before you start testing.
- Pays cash
- Amounts are not published; ask before you invest time.
- Report by email
- [email protected]
Rewards
What the company's own policy page says it pays.
The policy page has no reward table. Here is what it says, in its own words.
- Lowest reward
-
$50
For real findings with low exploitability or outside the financial ranges above, we may pay an ex-gratia reward starting at US$ 50 as recognition of the contribution, without setting a precedent for future cases.
- Pays cash
-
Yes
For real findings with low exploitability or outside the financial ranges above, we may pay an ex-gratia reward starting at US$ 50 as recognition of the contribution, without setting a precedent for future cases.
- Legal protection
-
Stated
We will not take legal action against researchers who follow the responsible disclosure guidelines described in this policy.
Summarised with AI from the company's policy, read 12 Nov 2026, and checked word for word against it. Read the original
Scope
3 assets you may test.
Wildcard domains 3
- *.bole.to
- *.kdoc.to
- *.kobana.com.br
Changes
Tracked since 12 Nov 2026. Last checked 5 hours ago.
No changes yet. When the rewards or scope move, you will see it here and in the RSS feed.
Public CVEs
Published vulnerabilities in this vendor's products, from the NVD.
No CVEs matched yet. We match NVD records by vendor name, so products sold under another name can be missing.